{"gene":"DTX3L","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":2003,"finding":"BBAP (DTX3L) functions as an E3 ubiquitin ligase capable of self-ubiquitination; it homodimerizes and heterodimerizes with DTX family members (DTX1) via unique N-termini, and heterodimerization with DTX1 enhances self-ubiquitination activity.","method":"In vitro ubiquitination assay (self-ubiquitination), yeast two-hybrid screen, in vivo co-immunoprecipitation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro E3 ligase activity demonstrated, reciprocal interaction mapping, multiple orthogonal methods in one study","pmids":["12670957"],"is_preprint":false},{"year":2006,"finding":"BBAP (DTX3L) regulates the subcellular localization of its binding partner BAL1 (PARP9) through a dynamic shuttling mechanism, establishing a functional requirement for coordinated BBAP and BAL1 expression.","method":"Subcellular fractionation, fluorescence microscopy showing dynamic shuttling","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct localization experiment with functional consequence described, single lab","pmids":["16809771"],"is_preprint":false},{"year":2009,"finding":"BBAP (DTX3L) selectively monoubiquitylates histone H4 at lysine 91 (H4K91); disruption of this modification leads to loss of chromatin-associated H4K20 methylase, reduction of mono- and dimethyl H4K20, and delayed 53BP1 foci formation at DNA damage sites.","method":"In vitro ubiquitination assay, site-specific mutagenesis, chromatin immunoprecipitation, immunofluorescence for 53BP1 foci","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vitro biochemical reconstitution with defined substrate site, mutagenesis, and functional cellular readout; replicated in subsequent studies","pmids":["19818714"],"is_preprint":false},{"year":2012,"finding":"BAL1 (PARP9) macrodomain-containing protein and its partner BBAP (DTX3L) E3 ligase are recruited to DNA damage sites via PARP1-dependent PARylation; BBAP-mediated local ubiquitylation then promotes 53BP1 and BRCA1 recruitment; this DDR pathway operates independently of ATM, MDC1, and RNF8.","method":"Genetic epistasis (ATM/MDC1/RNF8 knockouts), laser-stripe DNA damage + live-cell imaging, co-immunoprecipitation, ubiquitylation assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — epistasis analysis combined with multiple orthogonal methods, defines pathway position, replicated across labs","pmids":["23230272"],"is_preprint":false},{"year":2014,"finding":"DTX3L forms a protein complex with ARTD8 (PARP14) and ARTD9 (PARP9); DTX3L together with ARTD9 act as repressors of IRF1 expression in metastatic prostate cancer cells, and DTX3L together with STAT1 and STAT3 is implicated in cell migration.","method":"Co-immunoprecipitation, RNA interference knockdown, immunofluorescence","journal":"Molecular cancer","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-IP and functional KD with defined readouts, single lab, multiple methods","pmids":["24886089"],"is_preprint":false},{"year":2015,"finding":"The PARP9-DTX3L complex acts as an E3 ubiquitin ligase that ubiquitylates host histone H2BJ to promote interferon-stimulated gene expression, and also targets viral 3C proteases for degradation via the immunoproteasome; the complex interacts with STAT1 to enhance interferon signaling.","method":"Co-immunoprecipitation, in vitro ubiquitination assay, transgenic mouse model, transduced human cells with STAT1 variant, viral infection assays","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (in vitro biochemical + mouse model + cellular), two distinct substrates characterized","pmids":["26479788"],"is_preprint":false},{"year":2015,"finding":"DTX3L (Dtx3l) promotes melanoma invasion and metastasis through the FAK/PI3K/AKT signaling pathway but not through MEK/ERK signaling; depletion of DTX3L decreased FAK/PI3K/AKT activity.","method":"siRNA knockdown, western blot for pathway components, invasion/migration assays, transgenic mouse melanoma model","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — KD with defined pathway readouts, both mouse and human cell lines, single lab","pmids":["26033450"],"is_preprint":false},{"year":2015,"finding":"HDAC1,2 inhibition increases H4K91 acetylation and decreases BBAP (DTX3L)-mediated H4K91 monoubiquitination, thereby impairing BBAP-dependent DSB repair; H4K91 is a shared substrate for both acetylation and BBAP-mediated ubiquitination.","method":"Pharmacological HDAC1,2 inhibition, western blot for H4K91 modifications, DNA damage repair assays","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined PTM crosstalk at specific residue with functional DSB repair readout, single lab","pmids":["25605023"],"is_preprint":false},{"year":2017,"finding":"The DTX3L/PARP9 (Dtx3L/Parp9) heterodimer mediates NAD+-dependent mono-ADP-ribosylation of the C-terminal glycine 76 (Gly76) of ubiquitin exclusively in the context of ubiquitin processing by E1 and E2 enzymes; ADP-ribosylation of Ub Gly76 precludes ubiquitylation of substrates. PARP9 macrodomain binding to poly(ADP-ribose) increases E3 activity, and mutation of the NAD+ binding site in PARP9 increases DNA repair activity of the heterodimer.","method":"In vitro reconstituted ubiquitin processing assay, mass spectrometry for ADP-ribosylation site, site-directed mutagenesis, biochemical NAD+ titration","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with mutagenesis and MS-based site mapping, multiple orthogonal methods, defines novel enzymatic mechanism","pmids":["28525742"],"is_preprint":false},{"year":2021,"finding":"IFN-response-induced ADP-ribosylation of host proteins is dependent on PARP9 and its binding partner DTX3L; however, deletion of either PARP9 or DTX3L does not impair IFN signaling or induction of IFN-responsive genes, indicating that PARP9/DTX3L-dependent ADP-ribosylation is a downstream effector rather than a mediator of IFN signaling. The SARS-CoV-2 Nsp3 macrodomain reverses this IFN-induced ADP-ribosylation.","method":"Immunofluorescence-based ADP-ribosylation assay, PARP9/DTX3L knockout cell lines, ectopic expression of Nsp3 macrodomain","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with orthogonal functional readout, replicated in companion paper (PMID:38834853), clearly distinguishes positive from negative findings","pmids":["34358560"],"is_preprint":false},{"year":2022,"finding":"The DTX3L D3 domain (residues 230-510) mediates interaction with PARP9 with nanomolar affinity and 1:1 stoichiometry; the DTX3L N-terminal region (residues 1-200) mediates assembly into a higher-molecular-weight oligomer. ADP-ribosylation of ubiquitin at Gly76 by DTX3L-PARP9 is reversible in vitro by several macrodomain-type hydrolases.","method":"Recombinant protein production, binding affinity measurements, size exclusion chromatography, in vitro ADP-ribosylation reversal assays","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with domain-mapping and quantitative binding measurements, multiple biochemical methods","pmids":["35037691"],"is_preprint":false},{"year":2023,"finding":"During an initial DNA damage response, DTX3L rapidly co-localizes with p53 at PARP1-PARylated DNA damage sites, polyubiquitylates p53 at its lysine-rich C-terminal domain, and targets p53 for proteasomal degradation; DTX3L knockout significantly increases and prolongs p53 retention at these sites.","method":"Co-immunoprecipitation, ubiquitination assay, DTX3L knockout cells, immunofluorescence for p53 at damage sites, proteasome inhibitor experiments","journal":"iScience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP, KO with defined cellular phenotype, ubiquitination assay, multiple orthogonal methods","pmids":["37096048"],"is_preprint":false},{"year":2023,"finding":"DTX3L ubiquitinates NLRP3 (interacting via the NLRP3 LRR domain and DTX3L RING domain), resulting in NLRP3 degradation and regulation of OGD/R-induced pyroptosis in R28 cells.","method":"Co-immunoprecipitation, mass spectrometry for interactors, domain-mapping experiments, ubiquitination assays, pyroptosis assays (LDH, staining)","journal":"Biochimica et biophysica acta. Molecular cell research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-IP with domain mapping and functional pyroptosis readout, single lab","pmids":["36706922"],"is_preprint":false},{"year":2023,"finding":"DTX3L ubiquitinates TBK1 at K30 and K401 via K63-linked ubiquitination; DTX3L also binds the tyrosine kinase SRC and together they enhance TBK1 phosphorylation, forming a positive-feedback loop (IFN-β-ETS1-DTX3L-TBK1) that amplifies type I interferon antiviral responses.","method":"Co-immunoprecipitation, in vitro ubiquitination assay with site-specific mutagenesis (K30, K401), phosphorylation assays, reporter assays for IFN-β promoter activity","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ubiquitination site mapping by mutagenesis plus phosphorylation functional readout, single lab","pmids":["37255478"],"is_preprint":false},{"year":2023,"finding":"DTX3L mediates ubiquitination and degradation of cGAS, suppressing cGAS-STING pathway activation and antitumor immunity in pancreatic cancer cells.","method":"Co-immunoprecipitation, ubiquitination assay, DTX3L silencing with cGAS-STING pathway activation readout","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — single lab, co-IP plus functional knockdown, limited mechanistic detail in abstract","pmids":["37774567"],"is_preprint":false},{"year":2023,"finding":"Dual ADP-ribosylation of closely spaced cysteines in the androgen receptor (AR) mediates high-affinity recognition by the DTX3L/PARP9 complex (Kd = 80.5 nM for dual vs. single ADP-ribosylated peptide); oligomerization of DTX3L/PARP9 is required for efficient ADP-ribosyl-peptide interaction.","method":"Synthetic peptide chemistry, fluorescence binding assays, oligomerization mutant analysis","journal":"ACS chemical biology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — quantitative binding measurements with defined substrates and oligomerization mutant, multiple orthogonal methods","pmids":["37939374"],"is_preprint":false},{"year":2023,"finding":"DTX3L binds EGFR and prevents its ubiquitination-mediated degradation, leading to EGFR upregulation that activates the FAK/PI3K/Akt pathway to promote pancreatic cancer progression.","method":"Co-immunoprecipitation, ubiquitination assay, western blot for pathway activation, in vivo orthotopic tumor model","journal":"Biochemical genetics","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-IP and ubiquitination assay with pathway readout, single lab","pmids":["37460862"],"is_preprint":false},{"year":2024,"finding":"PARP14 is the major ADP-ribosyltransferase responsible for IFN-induced ADP-ribosylation; the PARP9/DTX3L complex regulates PARP14 protein levels via post-translational mechanisms and through PARP9 macrodomain 1 hydrolytic activity. PARP9/DTX3L and PARP14 co-localize to IFN-induced cytoplasmic inclusions, and DTX3L and PARP14 are themselves targets of PARP14 ADP-ribosylation. Interaction of DTX3L suppresses PARP14 auto-ADP-ribosylation and promotes trans-ADP-ribosylation of PARP9 and DTX3L.","method":"Improved mono-ADP-ribosylation antibody detection, PARP14/PARP9/DTX3L knockout cells, immunofluorescence co-localization, biochemical interaction assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple KO lines with orthogonal biochemical and imaging methods, published as companion papers with independent replication","pmids":["38834853","38834852"],"is_preprint":false},{"year":2024,"finding":"KH-like domains in PARP9, DTX3L, and PARP14 mediate protein-protein interactions: PARP9-DTX3L and PARP14-DTX3L interactions are coordinated through KH-like domains, and DTX3L homodimerization is also coordinated by a KH-like domain and disrupted by site-specific mutation. DTX3L interaction in vitro suppresses PARP14 auto-ADP-ribosylation and promotes trans-ADP-ribosylation of PARP9 and DTX3L.","method":"In vitro binding assays, site-directed mutagenesis of KH-like domain, ADP-ribosylation activity assays, PARP14 truncation rescue experiments","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis with functional activity readout, in vitro reconstitution, single lab","pmids":["38182103"],"is_preprint":false},{"year":2024,"finding":"The DTX3L N-terminal D2 domain forms a tetramer with D2 symmetry (crystal structure resolved), containing a major interface of 973 Ų and a minor interface of 415 Ų; native MS confirms monomers, dimers, and tetramers. The D1-D2 region is dispensable for DTX3L-PARP9 heterodimer formation but required for oligomeric complex assembly and efficient reader function for ADP-ribosylated androgen receptor.","method":"X-ray crystallography, native mass spectrometry, DTX3L knockout cell reconstitution with D1-D2 deletion mutant, ADP-ribosyl binding assays","journal":"Protein science : a publication of the Protein Society","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus native MS plus functional cellular reconstitution with defined mutant, multiple orthogonal methods","pmids":["38511494"],"is_preprint":false},{"year":2024,"finding":"DTX3L ubiquitinates single-stranded DNA and RNA (preferentially at the 3'-terminal adenosine), as well as double-stranded DNA with a 3' overhang of ≥2 nucleotides, via ester bond formation; the minimal catalytically competent fragment comprises the C-terminal RING and DTC domains (RD). NMR and biochemical analyses show the DTC domain binds single-stranded DNA and facilitates Ub transfer from RING-bound E2-Ub. This ubiquitylation is reversible by deubiquitinases (USP2, JOSD1, SARS-CoV-2 PLpro). This activity is shared with DTX3 but not DTX1, DTX2, or DTX4.","method":"In vitro ubiquitination assays with DNA/RNA substrates, NMR spectroscopy, domain truncation analysis, DUB reversal assays, comparative analysis across DTX family members","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 / Strong — NMR structure plus in vitro reconstitution plus domain mutagenesis, multiple orthogonal methods, complementary independent study (PMID:39242775)","pmids":["39377462","39242775"],"is_preprint":false},{"year":2024,"finding":"DTX3L ubiquitinates TIRR at lysine 187, promoting XPO1-mediated nuclear export and proteasomal degradation of TIRR upon DNA damage; this releases 53BP1 from TIRR-mediated inhibition, altering DNA repair pathway choice toward NHEJ and increasing sensitivity to PARP inhibitors.","method":"Co-immunoprecipitation, ubiquitination assay with K187 site mapping, nuclear export inhibition (XPO1 inhibitor), DTX3L overexpression/knockdown, PARP inhibitor sensitivity assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — site-specific ubiquitination mapping with functional pathway readout (NHEJ/HR repair choice + PARP inhibitor sensitivity), multiple orthogonal methods","pmids":["39632881"],"is_preprint":false},{"year":2025,"finding":"DTX3L ubiquitinates USP28 leading to its proteasomal degradation; reciprocally, USP28 deubiquitinates both itself and DTX3L. This antagonistic cross-regulation fine-tunes DSB repair in NHEJ, HR, SSA, and MMEJ pathways; detrimental effects of USP28 depletion on DSB repair are rescued by concurrent DTX3L knockdown.","method":"Co-immunoprecipitation, ubiquitination assays, deubiquitination assays, siRNA knockdown epistasis, multiple DSB repair pathway reporters","journal":"iScience","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, ubiquitination and DUB assays, epistasis knockdown rescue, multiple repair pathway readouts","pmids":["40703443"],"is_preprint":false},{"year":2025,"finding":"DTX3L acts as an E3 ubiquitin ligase for SATB2 in glioma stem cells, ubiquitinating SATB2 at K266 to promote its GSK-3β-dependent proteasomal degradation; USP10 opposes this by deubiquitinating SATB2 at the same residue via mutually exclusive interactions. DTX3L overexpression downregulates SATB2 and inhibits GSC self-renewal and GBM growth.","method":"Co-immunoprecipitation, ubiquitination assay with K266 site mapping, USP10/DTX3L overexpression/knockdown, rescue with SATB2 overexpression, in vivo tumor models","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — site-specific ubiquitination with competing enzyme identified, rescue experiments, in vivo validation","pmids":["41507172"],"is_preprint":false},{"year":2025,"finding":"DTX3L ubiquitinates LATS2 (a Hippo pathway tumor suppressor) to promote its degradation in renal cell carcinoma cells, activating downstream oncogenic signaling.","method":"Proteomic screening, co-immunoprecipitation, ubiquitination assay, in vitro and in vivo tumor growth assays","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — co-IP and ubiquitination assay, limited mechanistic detail in abstract, single lab","pmids":["41203184"],"is_preprint":false},{"year":2026,"finding":"DTX3L directly interacts with and ubiquitinates SNAI1, leading to its GSK-3β-dependent proteasomal degradation, thereby suppressing EMT and metastasis in gastric cancer; TGF-β1-induced miR-135b-5p downregulates DTX3L, stabilizing SNAI1 and enhancing EMT.","method":"Co-immunoprecipitation, ubiquitination assay, proteasome inhibitor experiments, miR-135b-5p manipulation, cell migration/invasion assays, organoid and animal models","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-IP and ubiquitination with functional rescue, multiple model systems, single lab","pmids":["41972409"],"is_preprint":false},{"year":2026,"finding":"DTX3L binds PKCα through its RING domain and targets PKCα for K48-linked ubiquitination and proteasomal degradation, thereby attenuating p38 MAPK phosphorylation and driving breast cancer progression.","method":"Co-immunoprecipitation, ubiquitination assay with K48-linkage specification, RING domain binding analysis, transcriptomic profiling after DTX3L knockdown, western blot for p38 phosphorylation","journal":"International journal of biological macromolecules","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-IP with domain mapping and K48-linkage characterization, functional pathway readout, single lab","pmids":["41679478"],"is_preprint":false},{"year":2016,"finding":"Translocation of BBAP (DTX3L) from the cytoplasm to the nucleus (induced by paclitaxel treatment) decreases the metastatic ability of vemurafenib-resistant melanoma cells, with downregulation of phospho-FAK and N-cadherin and upregulation of p21 and E-cadherin.","method":"Immunofluorescence for subcellular localization, migration/invasion assays, western blot for downstream markers","journal":"Molecular medicine reports","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single localization method linked to functional readout, no mechanistic detail on how nuclear BBAP mediates the effect","pmids":["27922665"],"is_preprint":false},{"year":2020,"finding":"DTX3L and ARTD9 associate with STAT1 under TNF-α-stimulated conditions in fibroblast-like synoviocytes and modulate STAT1 nuclear localization and transcriptional activity, promoting MMP-9 and IL-6 expression.","method":"Co-immunoprecipitation, immunofluorescence for STAT1 nuclear localization, RNA interference knockdown, western blot","journal":"Tissue & cell","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, co-IP plus immunofluorescence without detailed mechanistic dissection of how DTX3L modulates STAT1","pmids":["32473705"],"is_preprint":false}],"current_model":"DTX3L (BBAP/RNF143) is a multifunctional RING-type E3 ubiquitin ligase that obligately heterodimerizes with PARP9 (BAL1/ARTD9) via its D3 domain and homo-oligomerizes via its D1-D2 domains; the DTX3L-PARP9 complex has dual enzymatic activities: classic E3 ubiquitin ligase activity targeting histones (H4K91, H2BJ), p53, TIRR, USP28, NLRP3, cGAS, LATS2, EGFR, PKCα, SATB2, and SNAI1 for ubiquitylation or degradation, and NAD+-dependent mono-ADP-ribosyltransferase activity that modifies the C-terminal Gly76 of ubiquitin to competitively inhibit its own ligase function; oligomerization of DTX3L is required for efficient reading of ADP-ribosylated substrates such as the androgen receptor; the complex is recruited to PARP1-PARylated DNA damage sites to regulate the DDR (promoting BRCA1/53BP1 recruitment and controlling p53 abundance), modulates IFN signaling (serving as a downstream effector of IFN-induced ADP-ribosylation via PARP14 regulation), and promotes antiviral responses by ubiquitylating TBK1 and viral proteases; DTX3L also directly ubiquitylates single-stranded nucleic acids at their 3' ends via its RING-DTC domains."},"narrative":{"mechanistic_narrative":"DTX3L (BBAP) is a RING-type E3 ubiquitin ligase that operates as the catalytic engine of an obligate heterodimer with the macrodomain protein PARP9, coordinating protein ubiquitylation, ADP-ribosylation, and the DNA damage response [PMID:12670957, PMID:23230272, PMID:28525742]. DTX3L homo-oligomerizes through an N-terminal D1–D2 region — its D2 domain crystallizes as a tetramer — while binding PARP9 with nanomolar affinity through a distinct D3 domain; oligomerization is dispensable for heterodimer formation but required for efficient reading of ADP-ribosylated substrates such as the androgen receptor [PMID:35037691, PMID:37939374, PMID:38511494]. The complex carries two opposing enzymatic outputs: classical E3 ligase activity and a PARP9-dependent NAD+-driven mono-ADP-ribosylation of ubiquitin's C-terminal Gly76 that competitively blocks substrate ubiquitylation, a modification reversible by macrodomain hydrolases [PMID:28525742, PMID:35037691]. In the DNA damage response, DTX3L-PARP9 is recruited to PARP1-PARylated lesions independently of the ATM/MDC1/RNF8 axis, where DTX3L monoubiquitylates histone H4 at K91 to promote 53BP1 and BRCA1 recruitment, and additionally polyubiquitylates p53 for proteasomal degradation at damage sites [PMID:19818714, PMID:23230272, PMID:37096048]. DTX3L further tunes repair pathway choice by ubiquitylating TIRR (K187) to release 53BP1 and by reciprocally antagonizing the deubiquitinase USP28 [PMID:39632881, PMID:40703443]. In immunity, the PARP9-DTX3L complex ubiquitylates histone H2BJ to drive interferon-stimulated gene expression and degrades viral 3C proteases, amplifies type I interferon signaling by K63-ubiquitylating TBK1, and functions as a downstream effector of PARP14-driven IFN-induced ADP-ribosylation [PMID:26479788, PMID:37255478, PMID:38834853, PMID:38834852]. Beyond protein targets, DTX3L directly ubiquitylates single-stranded DNA and RNA at their 3' ends via its C-terminal RING-DTC domains through ester bond formation [PMID:39377462, PMID:39242775]. Across multiple cancers, DTX3L ubiquitylates a broad substrate set — including SATB2, SNAI1, LATS2, PKCα, and NLRP3, and stabilizes EGFR — to modulate proliferation, EMT, and signaling [PMID:36706922, PMID:37460862, PMID:41507172, PMID:41972409, PMID:41679478].","teleology":[{"year":2003,"claim":"Established that DTX3L is an active E3 ubiquitin ligase that dimerizes, answering whether the protein had intrinsic catalytic function and how it assembles.","evidence":"In vitro self-ubiquitination assay, yeast two-hybrid, and co-IP showing homo- and heterodimerization with DTX1","pmids":["12670957"],"confidence":"High","gaps":["No physiological substrate identified","PARP9 partnership not yet known"]},{"year":2006,"claim":"Linked DTX3L to PARP9 (BAL1) by showing it controls the partner's subcellular shuttling, establishing the functional interdependence later defined as obligate heterodimerization.","evidence":"Subcellular fractionation and fluorescence microscopy of dynamic shuttling","pmids":["16809771"],"confidence":"Medium","gaps":["Interaction interface not mapped","Enzymatic consequence of partnership undefined"]},{"year":2009,"claim":"Identified histone H4K91 as a specific DTX3L substrate and connected this monoubiquitylation to 53BP1 recruitment, defining a chromatin role in the DNA damage response.","evidence":"In vitro ubiquitination, site mutagenesis, ChIP, and 53BP1 foci immunofluorescence","pmids":["19818714"],"confidence":"High","gaps":["Recruitment mechanism to damage sites not defined","Relationship to canonical DDR ligases unresolved"]},{"year":2012,"claim":"Placed DTX3L-PARP9 in an ATM/MDC1/RNF8-independent DDR branch recruited via PARP1 PARylation, resolving where the pathway sits relative to canonical signaling.","evidence":"Genetic epistasis with knockouts, laser-stripe damage live imaging, co-IP, ubiquitylation assays","pmids":["23230272"],"confidence":"High","gaps":["Direct PAR-binding determinant of recruitment within complex not isolated here","Full substrate repertoire at lesions unknown"]},{"year":2015,"claim":"Defined dual immune effector roles: histone H2BJ ubiquitylation to promote ISG expression and degradation of viral 3C proteases, establishing the complex as an antiviral effector.","evidence":"Co-IP, in vitro ubiquitination, STAT1 variant cells, transgenic mouse, viral infection assays","pmids":["26479788"],"confidence":"High","gaps":["Mechanism of STAT1 cooperation not fully resolved","Substrate selectivity rules undefined"]},{"year":2017,"claim":"Discovered NAD+-dependent ADP-ribosylation of ubiquitin Gly76 by the heterodimer, revealing an autoregulatory switch that competitively inhibits the ligase's own activity.","evidence":"Reconstituted ubiquitin processing assay, MS site mapping, mutagenesis, NAD+ titration","pmids":["28525742"],"confidence":"High","gaps":["In vivo regulatory significance of the switch not established","Spatial/temporal control of the two activities unclear"]},{"year":2021,"claim":"Clarified that PARP9/DTX3L-dependent IFN-induced ADP-ribosylation is a downstream effector rather than a mediator of IFN signaling, and is reversed by SARS-CoV-2 Nsp3 macrodomain.","evidence":"Immunofluorescence ADP-ribosylation assay, PARP9/DTX3L knockout cells, Nsp3 ectopic expression","pmids":["34358560"],"confidence":"High","gaps":["Identity of the relevant transferase not yet resolved here","Functional consequence of the modified targets unknown"]},{"year":2022,"claim":"Mapped the modular architecture — D3 domain for nanomolar 1:1 PARP9 binding, N-terminal region for oligomerization — and showed ubiquitin-Gly76 ADP-ribosylation is reversible by macrodomain hydrolases.","evidence":"Recombinant protein binding affinity, SEC, in vitro reversal assays","pmids":["35037691"],"confidence":"High","gaps":["Functional role of oligomerization not yet demonstrated","Structural basis of assembly not resolved"]},{"year":2023,"claim":"Demonstrated DTX3L polyubiquitylates p53 at PARylated damage sites to limit its retention, defining a feedback control on DDR signaling intensity.","evidence":"Reciprocal co-IP, ubiquitination assay, DTX3L knockout cells, proteasome inhibition, immunofluorescence","pmids":["37096048"],"confidence":"High","gaps":["Physiological outcome on p53 transcriptional programs unaddressed","Linkage chain type on p53 not specified"]},{"year":2023,"claim":"Expanded the substrate set to immune and signaling regulators — NLRP3, TBK1, cGAS, EGFR — defining DTX3L as a node controlling inflammasome, interferon, and growth-factor pathways.","evidence":"Co-IP, domain mapping, site-specific ubiquitination (TBK1 K30/K401), functional pyroptosis/IFN/tumor readouts","pmids":["36706922","37255478","37774567","37460862"],"confidence":"Medium","gaps":["Most substrates from single labs without reciprocal cross-validation","Context-dependence (degradative vs signaling) of each substrate unresolved"]},{"year":2023,"claim":"Showed dual ADP-ribosylation of closely spaced cysteines generates a high-affinity reader site requiring DTX3L oligomerization, linking oligomeric assembly to substrate recognition.","evidence":"Synthetic peptide chemistry, fluorescence binding, oligomerization mutant analysis","pmids":["37939374"],"confidence":"High","gaps":["Downstream fate of the recognized androgen receptor not detailed","Generality of the dual-modification readout for other substrates untested"]},{"year":2024,"claim":"Resolved the structural basis of oligomerization (D2 tetramer crystal structure) and mapped KH-like domains mediating PARP9/PARP14/DTX3L interactions, connecting assembly to reader function and ADP-ribosylation regulation.","evidence":"X-ray crystallography, native MS, KO reconstitution with D1-D2 deletion, in vitro binding and mutagenesis","pmids":["38511494","38182103"],"confidence":"High","gaps":["Stoichiometry of the full multi-protein assembly in cells unresolved","Regulation of oligomeric state in vivo unknown"]},{"year":2024,"claim":"Identified PARP14 as the major IFN-induced transferase whose levels and activity are regulated by PARP9/DTX3L, defining the upstream-effector relationship in IFN ADP-ribosylation.","evidence":"Improved MAR antibody detection, PARP14/PARP9/DTX3L KO cells, co-localization imaging, biochemical assays","pmids":["38834853","38834852"],"confidence":"High","gaps":["Functional outcome of cytoplasmic inclusion formation unclear","Targets of PARP14 modification relevant to antiviral defense not enumerated"]},{"year":2024,"claim":"Revealed direct ubiquitylation of single-stranded nucleic acids at 3' ends by the RING-DTC module, establishing a non-protein substrate class for the ligase.","evidence":"In vitro ubiquitination with DNA/RNA substrates, NMR, domain truncation, DUB reversal, DTX family comparison","pmids":["39377462","39242775"],"confidence":"High","gaps":["Cellular function of nucleic-acid ubiquitylation unknown","In vivo substrates and biological pathway unestablished"]},{"year":2024,"claim":"Showed DTX3L ubiquitylates TIRR (K187) to drive its nuclear export and degradation, releasing 53BP1 and biasing repair toward NHEJ with PARP-inhibitor sensitization.","evidence":"Co-IP, K187 site mapping, XPO1 inhibition, overexpression/knockdown, PARP inhibitor sensitivity","pmids":["39632881"],"confidence":"High","gaps":["Integration with the H4K91/p53 DDR functions not unified","Trigger linking damage to TIRR ubiquitylation unspecified"]},{"year":2025,"claim":"Established reciprocal antagonism between DTX3L and USP28 that fine-tunes choice across multiple DSB repair pathways, adding a deubiquitinase counterweight to DTX3L control of repair.","evidence":"Reciprocal co-IP, ubiquitination/deubiquitination assays, knockdown epistasis rescue, repair pathway reporters","pmids":["40703443"],"confidence":"High","gaps":["Stoichiometric balance setting the switch unknown","Whether this acts at chromatin or globally unresolved"]},{"year":2025,"claim":"Extended DTX3L's degradative substrate range in cancer to SATB2 (K266) and LATS2, with competing deubiquitinase USP10 for SATB2, linking DTX3L to glioma stemness and Hippo signaling.","evidence":"Co-IP, site-specific ubiquitination, competing-enzyme analysis, rescue, in vivo tumor models","pmids":["41507172","41203184"],"confidence":"High","gaps":["GSK-3β dependence mechanism not fully dissected","Tissue specificity of substrate selection unexplained"]},{"year":2026,"claim":"Added SNAI1 and PKCα as degradative substrates controlling EMT and MAPK signaling, with upstream miRNA regulation of DTX3L itself, broadening its role in metastasis suppression and progression.","evidence":"Co-IP, ubiquitination assays (K48-linkage for PKCα), miR-135b-5p manipulation, organoid and animal models","pmids":["41972409","41679478"],"confidence":"Medium","gaps":["Single-lab findings without reciprocal validation","Reconciliation of pro- and anti-tumor roles across tissues unresolved"]},{"year":null,"claim":"How DTX3L selects among its many protein and nucleic-acid substrates, and how the competing ubiquitylation and ubiquitin-ADP-ribosylation activities are spatially and temporally partitioned in cells, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying model for substrate selectivity","In vivo regulation of the ligase-vs-ADP-ribosyltransferase switch undefined","Function of nucleic-acid ubiquitylation in cells unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[8,17]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,2,5,11,21,22]},{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[0,2,20]},{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[20]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[2,5]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[20]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[20]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,2,11]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[1,17]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[2,3,11]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[2,3,11,21,22]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[5,13,17]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,8,11]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[2,5]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[16,23,24,25,26]}],"complexes":["DTX3L-PARP9 heterodimer","DTX3L-PARP9-PARP14 complex"],"partners":["PARP9","PARP14","DTX1","STAT1","USP28","EGFR","TBK1","TIRR"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q8TDB6","full_name":"E3 ubiquitin-protein ligase DTX3L","aliases":["B-lymphoma- and BAL-associated protein","Protein deltex-3-like","RING-type E3 ubiquitin transferase DTX3L","Rhysin-2","Rhysin2"],"length_aa":740,"mass_kda":83.6,"function":"E3 ubiquitin-protein ligase which, in association with ADP-ribosyltransferase PARP9, plays a role in DNA damage repair and in interferon-mediated antiviral responses (PubMed:12670957, PubMed:19818714, PubMed:23230272, PubMed:26479788). Monoubiquitinates several histones, including histone H2A, H2B, H3 and H4 (PubMed:28525742). In response to DNA damage, mediates monoubiquitination of 'Lys-91' of histone H4 (H4K91ub1) (PubMed:19818714). The exact role of H4K91ub1 in DNA damage response is still unclear but it may function as a licensing signal for additional histone H4 post-translational modifications such as H4 'Lys-20' methylation (H4K20me) (PubMed:19818714). PARP1-dependent PARP9-DTX3L-mediated ubiquitination promotes the rapid and specific recruitment of 53BP1/TP53BP1, UIMC1/RAP80, and BRCA1 to DNA damage sites (PubMed:23230272). By monoubiquitinating histone H2B H2BC9/H2BJ and thereby promoting chromatin remodeling, positively regulates STAT1-dependent interferon-stimulated gene transcription and thus STAT1-mediated control of viral replication (PubMed:26479788). Independently of its catalytic activity, promotes the sorting of chemokine receptor CXCR4 from early endosome to lysosome following CXCL12 stimulation by reducing E3 ligase ITCH activity and thus ITCH-mediated ubiquitination of endosomal sorting complex required for transport ESCRT-0 components HGS and STAM (PubMed:24790097). In addition, required for the recruitment of HGS and STAM to early endosomes (PubMed:24790097). In association with PARP9, plays a role in antiviral responses by mediating 'Lys-48'-linked ubiquitination of encephalomyocarditis virus (EMCV) and human rhinovirus (HRV) C3 proteases and thus promoting their proteasomal-mediated degradation (PubMed:26479788)","subcellular_location":"Cytoplasm; Nucleus; Early endosome membrane; Lysosome membrane","url":"https://www.uniprot.org/uniprotkb/Q8TDB6/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DTX3L","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DTX3L","total_profiled":1310},"omim":[{"mim_id":"613143","title":"DELTEX E3 UBIQUITIN LIGASE 3L; DTX3L","url":"https://www.omim.org/entry/613143"},{"mim_id":"612065","title":"POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 9; PARP9","url":"https://www.omim.org/entry/612065"},{"mim_id":"603328","title":"MUSASHI RNA BINDING PROTEIN 1; MSI1","url":"https://www.omim.org/entry/603328"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DTX3L"},"hgnc":{"alias_symbol":["BBAP","RNF143"],"prev_symbol":[]},"alphafold":{"accession":"Q8TDB6","domains":[{"cath_id":"3.30.1370","chopping":"236-304","consensus_level":"medium","plddt":87.3562,"start":236,"end":304},{"cath_id":"3.30.1370,3.30.310","chopping":"378-445","consensus_level":"high","plddt":85.9872,"start":378,"end":445},{"cath_id":"3.30.390.130","chopping":"614-738","consensus_level":"high","plddt":94.8825,"start":614,"end":738},{"cath_id":"3.30.70","chopping":"12-88","consensus_level":"high","plddt":84.3149,"start":12,"end":88},{"cath_id":"3.30.70","chopping":"139-195","consensus_level":"high","plddt":82.8898,"start":139,"end":195},{"cath_id":"3.30.70","chopping":"307-363","consensus_level":"medium","plddt":86.1484,"start":307,"end":363},{"cath_id":"3.30.70","chopping":"451-509","consensus_level":"high","plddt":77.9663,"start":451,"end":509}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TDB6","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TDB6-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TDB6-F1-predicted_aligned_error_v6.png","plddt_mean":76.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DTX3L","jax_strain_url":"https://www.jax.org/strain/search?query=DTX3L"},"sequence":{"accession":"Q8TDB6","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8TDB6.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8TDB6/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TDB6"}},"corpus_meta":[{"pmid":"26479788","id":"PMC_26479788","title":"PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection.","date":"2015","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26479788","citation_count":187,"is_preprint":false},{"pmid":"28525742","id":"PMC_28525742","title":"Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9.","date":"2017","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/28525742","citation_count":175,"is_preprint":false},{"pmid":"19818714","id":"PMC_19818714","title":"BBAP monoubiquitylates histone H4 at lysine 91 and selectively modulates the DNA damage response.","date":"2009","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/19818714","citation_count":139,"is_preprint":false},{"pmid":"12670957","id":"PMC_12670957","title":"The BAL-binding protein BBAP and related Deltex family members exhibit ubiquitin-protein isopeptide ligase activity.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12670957","citation_count":127,"is_preprint":false},{"pmid":"16809771","id":"PMC_16809771","title":"BAL1 and BBAP are regulated by a gamma interferon-responsive bidirectional promoter and are overexpressed in diffuse large B-cell lymphomas with a prominent inflammatory infiltrate.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16809771","citation_count":106,"is_preprint":false},{"pmid":"23230272","id":"PMC_23230272","title":"BAL1 and its partner E3 ligase, BBAP, link Poly(ADP-ribose) activation, ubiquitylation, and double-strand DNA repair independent of ATM, MDC1, and RNF8.","date":"2012","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23230272","citation_count":99,"is_preprint":false},{"pmid":"24886089","id":"PMC_24886089","title":"DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells.","date":"2014","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24886089","citation_count":97,"is_preprint":false},{"pmid":"34358560","id":"PMC_34358560","title":"The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling.","date":"2021","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34358560","citation_count":95,"is_preprint":false},{"pmid":"26033450","id":"PMC_26033450","title":"Deltex-3-like (DTX3L) stimulates metastasis of melanoma through FAK/PI3K/AKT but not MEK/ERK pathway.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26033450","citation_count":50,"is_preprint":false},{"pmid":"38834853","id":"PMC_38834853","title":"PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation.","date":"2024","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/38834853","citation_count":43,"is_preprint":false},{"pmid":"25605023","id":"PMC_25605023","title":"HDAC1,2 inhibition impairs EZH2- and BBAP-mediated DNA repair to overcome chemoresistance in EZH2 gain-of-function mutant diffuse large B-cell lymphoma.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25605023","citation_count":37,"is_preprint":false},{"pmid":"36706922","id":"PMC_36706922","title":"DTX3L induced NLRP3 ubiquitination inhibit R28 cell pyroptosis in OGD/R injury.","date":"2023","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/36706922","citation_count":32,"is_preprint":false},{"pmid":"38834852","id":"PMC_38834852","title":"PARP14 is regulated by the PARP9/DTX3L complex and promotes interferon γ-induced ADP-ribosylation.","date":"2024","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/38834852","citation_count":28,"is_preprint":false},{"pmid":"35037691","id":"PMC_35037691","title":"Reconstitution of the DTX3L-PARP9 complex reveals determinants for high-affinity heterodimerization and multimeric assembly.","date":"2022","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/35037691","citation_count":28,"is_preprint":false},{"pmid":"38182103","id":"PMC_38182103","title":"KH-like Domains in PARP9/DTX3L and PARP14 Coordinate Protein-Protein Interactions to Promote Cancer Cell Survival.","date":"2024","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/38182103","citation_count":27,"is_preprint":false},{"pmid":"28627634","id":"PMC_28627634","title":"DTX3L is upregulated in glioma and is associated with glioma progression.","date":"2017","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28627634","citation_count":26,"is_preprint":false},{"pmid":"39696540","id":"PMC_39696540","title":"Spatial transcriptome profiling identifies DTX3L and BST2 as key biomarkers in esophageal squamous cell carcinoma tumorigenesis.","date":"2024","source":"Genome medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39696540","citation_count":23,"is_preprint":false},{"pmid":"37096048","id":"PMC_37096048","title":"DTX3L E3 ligase targets p53 for degradation at poly ADP-ribose polymerase-associated DNA damage sites.","date":"2023","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/37096048","citation_count":21,"is_preprint":false},{"pmid":"36421918","id":"PMC_36421918","title":"Activities and binding partners of E3 ubiquitin ligase DTX3L and its roles in cancer.","date":"2022","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/36421918","citation_count":20,"is_preprint":false},{"pmid":"39242775","id":"PMC_39242775","title":"Ubiquitylation of nucleic acids by DELTEX ubiquitin E3 ligase DTX3L.","date":"2024","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/39242775","citation_count":20,"is_preprint":false},{"pmid":"39377462","id":"PMC_39377462","title":"DTX3L ubiquitin ligase ubiquitinates single-stranded nucleic acids.","date":"2024","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/39377462","citation_count":20,"is_preprint":false},{"pmid":"35541235","id":"PMC_35541235","title":"Chemical activation of prolyl hydroxylase-2 by BBAP-1 down regulates hypoxia inducible factor-1α and fatty acid synthase for mammary gland chemoprevention.","date":"2018","source":"RSC advances","url":"https://pubmed.ncbi.nlm.nih.gov/35541235","citation_count":18,"is_preprint":false},{"pmid":"38042777","id":"PMC_38042777","title":"Circular RNA circEYA3 promotes the radiation resistance of hepatocellular carcinoma via the IGF2BP2/DTX3L axis.","date":"2023","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/38042777","citation_count":17,"is_preprint":false},{"pmid":"36614304","id":"PMC_36614304","title":"Silencing DTX3L Inhibits the Progression of Cervical Carcinoma by Regulating PI3K/AKT/mTOR Signaling Pathway.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36614304","citation_count":17,"is_preprint":false},{"pmid":"37255478","id":"PMC_37255478","title":"DTX3L Enhances Type I Interferon Antiviral Response by Promoting the Ubiquitination and Phosphorylation of TBK1.","date":"2023","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/37255478","citation_count":15,"is_preprint":false},{"pmid":"28653881","id":"PMC_28653881","title":"Effects of DTX3L on the cell proliferation, adhesion, and drug resistance of multiple myeloma cells.","date":"2017","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28653881","citation_count":15,"is_preprint":false},{"pmid":"37460862","id":"PMC_37460862","title":"DTX3L Accelerates Pancreatic cancer Progression via FAK/PI3K/AKT Axis.","date":"2023","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37460862","citation_count":14,"is_preprint":false},{"pmid":"37774567","id":"PMC_37774567","title":"DTX3L mediated ubiquitination of cGAS suppresses antitumor immunity in pancreatic cancer.","date":"2023","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/37774567","citation_count":12,"is_preprint":false},{"pmid":"37939374","id":"PMC_37939374","title":"Synthetic Dual Cysteine-ADP Ribosylated Peptides from the Androgen Receptor are Recognized by the DTX3L/PARP9 Complex.","date":"2023","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/37939374","citation_count":12,"is_preprint":false},{"pmid":"39632881","id":"PMC_39632881","title":"DTX3L-mediated TIRR nuclear export and degradation regulates DNA repair pathway choice and PARP inhibitor sensitivity.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39632881","citation_count":9,"is_preprint":false},{"pmid":"38511494","id":"PMC_38511494","title":"Oligomerization mediated by the D2 domain of DTX3L is critical for DTX3L-PARP9 reading function of mono-ADP-ribosylated androgen receptor.","date":"2024","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/38511494","citation_count":7,"is_preprint":false},{"pmid":"27922665","id":"PMC_27922665","title":"Translocation of BBAP from the cytoplasm to the nucleus reduces the metastatic ability of vemurafenib-resistant SKMEL28 cells.","date":"2016","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/27922665","citation_count":6,"is_preprint":false},{"pmid":"40703443","id":"PMC_40703443","title":"The E3 ubiquitin ligase DTX3L and the deubiquitinase USP28 fine-tune DNA repair through mutual regulation of their protein levels.","date":"2025","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/40703443","citation_count":4,"is_preprint":false},{"pmid":"40695431","id":"PMC_40695431","title":"DTX3L E3 ligase: Molecular functions, regulatory mechanisms, and potential as a novel cancer biomarker and therapeutic target.","date":"2025","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/40695431","citation_count":3,"is_preprint":false},{"pmid":"32473705","id":"PMC_32473705","title":"DTX3L/ARTD9 contributes to inflammation of fibroblast-like synoviocytes by increasing STAT1 translocation.","date":"2020","source":"Tissue & cell","url":"https://pubmed.ncbi.nlm.nih.gov/32473705","citation_count":3,"is_preprint":false},{"pmid":"40194649","id":"PMC_40194649","title":"Small extracellular vesicles from adipose derived stem cells alleviate microglia activation and improve motor deficit of Parkinson's disease via miR-100-5p/DTX3L/STAT1 signaling axis.","date":"2025","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/40194649","citation_count":3,"is_preprint":false},{"pmid":"38076829","id":"PMC_38076829","title":"Oligomerisation mediated by the D2 domain of DTX3L is critical for DTX3L-PARP9 reading function of mono-ADP-ribosylated androgen receptor.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38076829","citation_count":2,"is_preprint":false},{"pmid":"37579950","id":"PMC_37579950","title":"Discovery of DTX3L inhibitors through a homogeneous FRET-based assay that monitors formation and removal of poly-ubiquitin chains.","date":"2023","source":"SLAS discovery : advancing life sciences R & D","url":"https://pubmed.ncbi.nlm.nih.gov/37579950","citation_count":2,"is_preprint":false},{"pmid":"39055911","id":"PMC_39055911","title":"Erratum: DTX3L E3 ligase targets p53 for degradation at poly ADP-ribose polymerase-associated DNA damage sites.","date":"2024","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/39055911","citation_count":1,"is_preprint":false},{"pmid":"41507172","id":"PMC_41507172","title":"USP10 promotes glioma stem cell maintenance and glioblastoma growth by antagonizing DTX3L-mediated SATB2 ubiquitination.","date":"2026","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/41507172","citation_count":0,"is_preprint":false},{"pmid":"41203184","id":"PMC_41203184","title":"DTX3L promotes renal cell carcinoma progression via ubiquitination and degradation of LATS2.","date":"2025","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/41203184","citation_count":0,"is_preprint":false},{"pmid":"41684454","id":"PMC_41684454","title":"LINC00973/DTX3L Axis Promotes Non-Small Cell Lung Cancer Progression and Serves as a Therapeutic Target.","date":"2026","source":"Smart medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41684454","citation_count":0,"is_preprint":false},{"pmid":"41935138","id":"PMC_41935138","title":"DTX3L promotes ovarian cancer progression and cisplatin resistance by activating JAK1/STAT1/OAS3 pathway.","date":"2026","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/41935138","citation_count":0,"is_preprint":false},{"pmid":"41883974","id":"PMC_41883974","title":"Investigating the functions and molecular mechanisms of DTX3L in cancer progression.","date":"2026","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/41883974","citation_count":0,"is_preprint":false},{"pmid":"41679478","id":"PMC_41679478","title":"E3 ubiquitin ligase DTX3L promotes breast cancer progression by enhancing PKCα ubiquitination and inhibiting the p38 MAPK signaling pathway.","date":"2026","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/41679478","citation_count":0,"is_preprint":false},{"pmid":"41930575","id":"PMC_41930575","title":"[Expression of Concern] DTX3L is upregulated in glioma and is associated with glioma progression.","date":"2026","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41930575","citation_count":0,"is_preprint":false},{"pmid":"41882821","id":"PMC_41882821","title":"Role of the H19/miR-423-5p/DTX3L Axis in Enhancing the Malignant Phenotype of Nasopharyngeal Carcinoma Cells.","date":"2026","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/41882821","citation_count":0,"is_preprint":false},{"pmid":"41972409","id":"PMC_41972409","title":"DTX3L Inhibits the EMT, Metastasis, and Stem-Like Features of Gastric Cancer Through Promoting GSK-3β Dependent SNAI1 Decay.","date":"2026","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/41972409","citation_count":0,"is_preprint":false},{"pmid":"42245128","id":"PMC_42245128","title":"KLF14 restrained NLRP3-mediated pyroptosis in sepsis-induced acute lung injury by activating DTX3L.","date":"2026","source":"Central-European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/42245128","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.09.30.25337006","title":"DNA Methylation Profiling in Childhood-Onset Lupus Reveals Distinct Epigenetic Clusters and Suggests Epigenetic Drivers of Disease Activity","date":"2025-10-02","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.30.25337006","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.07.18.602927","title":"Characterizing the Spatial Distribution of Dendritic RNA at Single Molecule Resolution","date":"2024-07-19","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.18.602927","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":26536,"output_tokens":7427,"usd":0.095506,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16528,"output_tokens":5859,"usd":0.114558,"stage2_stop_reason":"end_turn"},"total_usd":0.210064,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"BBAP (DTX3L) functions as an E3 ubiquitin ligase capable of self-ubiquitination; it homodimerizes and heterodimerizes with DTX family members (DTX1) via unique N-termini, and heterodimerization with DTX1 enhances self-ubiquitination activity.\",\n      \"method\": \"In vitro ubiquitination assay (self-ubiquitination), yeast two-hybrid screen, in vivo co-immunoprecipitation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro E3 ligase activity demonstrated, reciprocal interaction mapping, multiple orthogonal methods in one study\",\n      \"pmids\": [\"12670957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"BBAP (DTX3L) regulates the subcellular localization of its binding partner BAL1 (PARP9) through a dynamic shuttling mechanism, establishing a functional requirement for coordinated BBAP and BAL1 expression.\",\n      \"method\": \"Subcellular fractionation, fluorescence microscopy showing dynamic shuttling\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct localization experiment with functional consequence described, single lab\",\n      \"pmids\": [\"16809771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"BBAP (DTX3L) selectively monoubiquitylates histone H4 at lysine 91 (H4K91); disruption of this modification leads to loss of chromatin-associated H4K20 methylase, reduction of mono- and dimethyl H4K20, and delayed 53BP1 foci formation at DNA damage sites.\",\n      \"method\": \"In vitro ubiquitination assay, site-specific mutagenesis, chromatin immunoprecipitation, immunofluorescence for 53BP1 foci\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vitro biochemical reconstitution with defined substrate site, mutagenesis, and functional cellular readout; replicated in subsequent studies\",\n      \"pmids\": [\"19818714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"BAL1 (PARP9) macrodomain-containing protein and its partner BBAP (DTX3L) E3 ligase are recruited to DNA damage sites via PARP1-dependent PARylation; BBAP-mediated local ubiquitylation then promotes 53BP1 and BRCA1 recruitment; this DDR pathway operates independently of ATM, MDC1, and RNF8.\",\n      \"method\": \"Genetic epistasis (ATM/MDC1/RNF8 knockouts), laser-stripe DNA damage + live-cell imaging, co-immunoprecipitation, ubiquitylation assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — epistasis analysis combined with multiple orthogonal methods, defines pathway position, replicated across labs\",\n      \"pmids\": [\"23230272\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DTX3L forms a protein complex with ARTD8 (PARP14) and ARTD9 (PARP9); DTX3L together with ARTD9 act as repressors of IRF1 expression in metastatic prostate cancer cells, and DTX3L together with STAT1 and STAT3 is implicated in cell migration.\",\n      \"method\": \"Co-immunoprecipitation, RNA interference knockdown, immunofluorescence\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-IP and functional KD with defined readouts, single lab, multiple methods\",\n      \"pmids\": [\"24886089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The PARP9-DTX3L complex acts as an E3 ubiquitin ligase that ubiquitylates host histone H2BJ to promote interferon-stimulated gene expression, and also targets viral 3C proteases for degradation via the immunoproteasome; the complex interacts with STAT1 to enhance interferon signaling.\",\n      \"method\": \"Co-immunoprecipitation, in vitro ubiquitination assay, transgenic mouse model, transduced human cells with STAT1 variant, viral infection assays\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (in vitro biochemical + mouse model + cellular), two distinct substrates characterized\",\n      \"pmids\": [\"26479788\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DTX3L (Dtx3l) promotes melanoma invasion and metastasis through the FAK/PI3K/AKT signaling pathway but not through MEK/ERK signaling; depletion of DTX3L decreased FAK/PI3K/AKT activity.\",\n      \"method\": \"siRNA knockdown, western blot for pathway components, invasion/migration assays, transgenic mouse melanoma model\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — KD with defined pathway readouts, both mouse and human cell lines, single lab\",\n      \"pmids\": [\"26033450\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HDAC1,2 inhibition increases H4K91 acetylation and decreases BBAP (DTX3L)-mediated H4K91 monoubiquitination, thereby impairing BBAP-dependent DSB repair; H4K91 is a shared substrate for both acetylation and BBAP-mediated ubiquitination.\",\n      \"method\": \"Pharmacological HDAC1,2 inhibition, western blot for H4K91 modifications, DNA damage repair assays\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined PTM crosstalk at specific residue with functional DSB repair readout, single lab\",\n      \"pmids\": [\"25605023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The DTX3L/PARP9 (Dtx3L/Parp9) heterodimer mediates NAD+-dependent mono-ADP-ribosylation of the C-terminal glycine 76 (Gly76) of ubiquitin exclusively in the context of ubiquitin processing by E1 and E2 enzymes; ADP-ribosylation of Ub Gly76 precludes ubiquitylation of substrates. PARP9 macrodomain binding to poly(ADP-ribose) increases E3 activity, and mutation of the NAD+ binding site in PARP9 increases DNA repair activity of the heterodimer.\",\n      \"method\": \"In vitro reconstituted ubiquitin processing assay, mass spectrometry for ADP-ribosylation site, site-directed mutagenesis, biochemical NAD+ titration\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with mutagenesis and MS-based site mapping, multiple orthogonal methods, defines novel enzymatic mechanism\",\n      \"pmids\": [\"28525742\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"IFN-response-induced ADP-ribosylation of host proteins is dependent on PARP9 and its binding partner DTX3L; however, deletion of either PARP9 or DTX3L does not impair IFN signaling or induction of IFN-responsive genes, indicating that PARP9/DTX3L-dependent ADP-ribosylation is a downstream effector rather than a mediator of IFN signaling. The SARS-CoV-2 Nsp3 macrodomain reverses this IFN-induced ADP-ribosylation.\",\n      \"method\": \"Immunofluorescence-based ADP-ribosylation assay, PARP9/DTX3L knockout cell lines, ectopic expression of Nsp3 macrodomain\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with orthogonal functional readout, replicated in companion paper (PMID:38834853), clearly distinguishes positive from negative findings\",\n      \"pmids\": [\"34358560\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The DTX3L D3 domain (residues 230-510) mediates interaction with PARP9 with nanomolar affinity and 1:1 stoichiometry; the DTX3L N-terminal region (residues 1-200) mediates assembly into a higher-molecular-weight oligomer. ADP-ribosylation of ubiquitin at Gly76 by DTX3L-PARP9 is reversible in vitro by several macrodomain-type hydrolases.\",\n      \"method\": \"Recombinant protein production, binding affinity measurements, size exclusion chromatography, in vitro ADP-ribosylation reversal assays\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with domain-mapping and quantitative binding measurements, multiple biochemical methods\",\n      \"pmids\": [\"35037691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"During an initial DNA damage response, DTX3L rapidly co-localizes with p53 at PARP1-PARylated DNA damage sites, polyubiquitylates p53 at its lysine-rich C-terminal domain, and targets p53 for proteasomal degradation; DTX3L knockout significantly increases and prolongs p53 retention at these sites.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, DTX3L knockout cells, immunofluorescence for p53 at damage sites, proteasome inhibitor experiments\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP, KO with defined cellular phenotype, ubiquitination assay, multiple orthogonal methods\",\n      \"pmids\": [\"37096048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"DTX3L ubiquitinates NLRP3 (interacting via the NLRP3 LRR domain and DTX3L RING domain), resulting in NLRP3 degradation and regulation of OGD/R-induced pyroptosis in R28 cells.\",\n      \"method\": \"Co-immunoprecipitation, mass spectrometry for interactors, domain-mapping experiments, ubiquitination assays, pyroptosis assays (LDH, staining)\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-IP with domain mapping and functional pyroptosis readout, single lab\",\n      \"pmids\": [\"36706922\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"DTX3L ubiquitinates TBK1 at K30 and K401 via K63-linked ubiquitination; DTX3L also binds the tyrosine kinase SRC and together they enhance TBK1 phosphorylation, forming a positive-feedback loop (IFN-β-ETS1-DTX3L-TBK1) that amplifies type I interferon antiviral responses.\",\n      \"method\": \"Co-immunoprecipitation, in vitro ubiquitination assay with site-specific mutagenesis (K30, K401), phosphorylation assays, reporter assays for IFN-β promoter activity\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ubiquitination site mapping by mutagenesis plus phosphorylation functional readout, single lab\",\n      \"pmids\": [\"37255478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"DTX3L mediates ubiquitination and degradation of cGAS, suppressing cGAS-STING pathway activation and antitumor immunity in pancreatic cancer cells.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, DTX3L silencing with cGAS-STING pathway activation readout\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, co-IP plus functional knockdown, limited mechanistic detail in abstract\",\n      \"pmids\": [\"37774567\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Dual ADP-ribosylation of closely spaced cysteines in the androgen receptor (AR) mediates high-affinity recognition by the DTX3L/PARP9 complex (Kd = 80.5 nM for dual vs. single ADP-ribosylated peptide); oligomerization of DTX3L/PARP9 is required for efficient ADP-ribosyl-peptide interaction.\",\n      \"method\": \"Synthetic peptide chemistry, fluorescence binding assays, oligomerization mutant analysis\",\n      \"journal\": \"ACS chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — quantitative binding measurements with defined substrates and oligomerization mutant, multiple orthogonal methods\",\n      \"pmids\": [\"37939374\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"DTX3L binds EGFR and prevents its ubiquitination-mediated degradation, leading to EGFR upregulation that activates the FAK/PI3K/Akt pathway to promote pancreatic cancer progression.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, western blot for pathway activation, in vivo orthotopic tumor model\",\n      \"journal\": \"Biochemical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-IP and ubiquitination assay with pathway readout, single lab\",\n      \"pmids\": [\"37460862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PARP14 is the major ADP-ribosyltransferase responsible for IFN-induced ADP-ribosylation; the PARP9/DTX3L complex regulates PARP14 protein levels via post-translational mechanisms and through PARP9 macrodomain 1 hydrolytic activity. PARP9/DTX3L and PARP14 co-localize to IFN-induced cytoplasmic inclusions, and DTX3L and PARP14 are themselves targets of PARP14 ADP-ribosylation. Interaction of DTX3L suppresses PARP14 auto-ADP-ribosylation and promotes trans-ADP-ribosylation of PARP9 and DTX3L.\",\n      \"method\": \"Improved mono-ADP-ribosylation antibody detection, PARP14/PARP9/DTX3L knockout cells, immunofluorescence co-localization, biochemical interaction assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple KO lines with orthogonal biochemical and imaging methods, published as companion papers with independent replication\",\n      \"pmids\": [\"38834853\", \"38834852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"KH-like domains in PARP9, DTX3L, and PARP14 mediate protein-protein interactions: PARP9-DTX3L and PARP14-DTX3L interactions are coordinated through KH-like domains, and DTX3L homodimerization is also coordinated by a KH-like domain and disrupted by site-specific mutation. DTX3L interaction in vitro suppresses PARP14 auto-ADP-ribosylation and promotes trans-ADP-ribosylation of PARP9 and DTX3L.\",\n      \"method\": \"In vitro binding assays, site-directed mutagenesis of KH-like domain, ADP-ribosylation activity assays, PARP14 truncation rescue experiments\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis with functional activity readout, in vitro reconstitution, single lab\",\n      \"pmids\": [\"38182103\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The DTX3L N-terminal D2 domain forms a tetramer with D2 symmetry (crystal structure resolved), containing a major interface of 973 Ų and a minor interface of 415 Ų; native MS confirms monomers, dimers, and tetramers. The D1-D2 region is dispensable for DTX3L-PARP9 heterodimer formation but required for oligomeric complex assembly and efficient reader function for ADP-ribosylated androgen receptor.\",\n      \"method\": \"X-ray crystallography, native mass spectrometry, DTX3L knockout cell reconstitution with D1-D2 deletion mutant, ADP-ribosyl binding assays\",\n      \"journal\": \"Protein science : a publication of the Protein Society\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus native MS plus functional cellular reconstitution with defined mutant, multiple orthogonal methods\",\n      \"pmids\": [\"38511494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DTX3L ubiquitinates single-stranded DNA and RNA (preferentially at the 3'-terminal adenosine), as well as double-stranded DNA with a 3' overhang of ≥2 nucleotides, via ester bond formation; the minimal catalytically competent fragment comprises the C-terminal RING and DTC domains (RD). NMR and biochemical analyses show the DTC domain binds single-stranded DNA and facilitates Ub transfer from RING-bound E2-Ub. This ubiquitylation is reversible by deubiquitinases (USP2, JOSD1, SARS-CoV-2 PLpro). This activity is shared with DTX3 but not DTX1, DTX2, or DTX4.\",\n      \"method\": \"In vitro ubiquitination assays with DNA/RNA substrates, NMR spectroscopy, domain truncation analysis, DUB reversal assays, comparative analysis across DTX family members\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — NMR structure plus in vitro reconstitution plus domain mutagenesis, multiple orthogonal methods, complementary independent study (PMID:39242775)\",\n      \"pmids\": [\"39377462\", \"39242775\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DTX3L ubiquitinates TIRR at lysine 187, promoting XPO1-mediated nuclear export and proteasomal degradation of TIRR upon DNA damage; this releases 53BP1 from TIRR-mediated inhibition, altering DNA repair pathway choice toward NHEJ and increasing sensitivity to PARP inhibitors.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay with K187 site mapping, nuclear export inhibition (XPO1 inhibitor), DTX3L overexpression/knockdown, PARP inhibitor sensitivity assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — site-specific ubiquitination mapping with functional pathway readout (NHEJ/HR repair choice + PARP inhibitor sensitivity), multiple orthogonal methods\",\n      \"pmids\": [\"39632881\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DTX3L ubiquitinates USP28 leading to its proteasomal degradation; reciprocally, USP28 deubiquitinates both itself and DTX3L. This antagonistic cross-regulation fine-tunes DSB repair in NHEJ, HR, SSA, and MMEJ pathways; detrimental effects of USP28 depletion on DSB repair are rescued by concurrent DTX3L knockdown.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assays, deubiquitination assays, siRNA knockdown epistasis, multiple DSB repair pathway reporters\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, ubiquitination and DUB assays, epistasis knockdown rescue, multiple repair pathway readouts\",\n      \"pmids\": [\"40703443\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DTX3L acts as an E3 ubiquitin ligase for SATB2 in glioma stem cells, ubiquitinating SATB2 at K266 to promote its GSK-3β-dependent proteasomal degradation; USP10 opposes this by deubiquitinating SATB2 at the same residue via mutually exclusive interactions. DTX3L overexpression downregulates SATB2 and inhibits GSC self-renewal and GBM growth.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay with K266 site mapping, USP10/DTX3L overexpression/knockdown, rescue with SATB2 overexpression, in vivo tumor models\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — site-specific ubiquitination with competing enzyme identified, rescue experiments, in vivo validation\",\n      \"pmids\": [\"41507172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DTX3L ubiquitinates LATS2 (a Hippo pathway tumor suppressor) to promote its degradation in renal cell carcinoma cells, activating downstream oncogenic signaling.\",\n      \"method\": \"Proteomic screening, co-immunoprecipitation, ubiquitination assay, in vitro and in vivo tumor growth assays\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — co-IP and ubiquitination assay, limited mechanistic detail in abstract, single lab\",\n      \"pmids\": [\"41203184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"DTX3L directly interacts with and ubiquitinates SNAI1, leading to its GSK-3β-dependent proteasomal degradation, thereby suppressing EMT and metastasis in gastric cancer; TGF-β1-induced miR-135b-5p downregulates DTX3L, stabilizing SNAI1 and enhancing EMT.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, proteasome inhibitor experiments, miR-135b-5p manipulation, cell migration/invasion assays, organoid and animal models\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-IP and ubiquitination with functional rescue, multiple model systems, single lab\",\n      \"pmids\": [\"41972409\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"DTX3L binds PKCα through its RING domain and targets PKCα for K48-linked ubiquitination and proteasomal degradation, thereby attenuating p38 MAPK phosphorylation and driving breast cancer progression.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay with K48-linkage specification, RING domain binding analysis, transcriptomic profiling after DTX3L knockdown, western blot for p38 phosphorylation\",\n      \"journal\": \"International journal of biological macromolecules\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-IP with domain mapping and K48-linkage characterization, functional pathway readout, single lab\",\n      \"pmids\": [\"41679478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Translocation of BBAP (DTX3L) from the cytoplasm to the nucleus (induced by paclitaxel treatment) decreases the metastatic ability of vemurafenib-resistant melanoma cells, with downregulation of phospho-FAK and N-cadherin and upregulation of p21 and E-cadherin.\",\n      \"method\": \"Immunofluorescence for subcellular localization, migration/invasion assays, western blot for downstream markers\",\n      \"journal\": \"Molecular medicine reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single localization method linked to functional readout, no mechanistic detail on how nuclear BBAP mediates the effect\",\n      \"pmids\": [\"27922665\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DTX3L and ARTD9 associate with STAT1 under TNF-α-stimulated conditions in fibroblast-like synoviocytes and modulate STAT1 nuclear localization and transcriptional activity, promoting MMP-9 and IL-6 expression.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence for STAT1 nuclear localization, RNA interference knockdown, western blot\",\n      \"journal\": \"Tissue & cell\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, co-IP plus immunofluorescence without detailed mechanistic dissection of how DTX3L modulates STAT1\",\n      \"pmids\": [\"32473705\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DTX3L (BBAP/RNF143) is a multifunctional RING-type E3 ubiquitin ligase that obligately heterodimerizes with PARP9 (BAL1/ARTD9) via its D3 domain and homo-oligomerizes via its D1-D2 domains; the DTX3L-PARP9 complex has dual enzymatic activities: classic E3 ubiquitin ligase activity targeting histones (H4K91, H2BJ), p53, TIRR, USP28, NLRP3, cGAS, LATS2, EGFR, PKCα, SATB2, and SNAI1 for ubiquitylation or degradation, and NAD+-dependent mono-ADP-ribosyltransferase activity that modifies the C-terminal Gly76 of ubiquitin to competitively inhibit its own ligase function; oligomerization of DTX3L is required for efficient reading of ADP-ribosylated substrates such as the androgen receptor; the complex is recruited to PARP1-PARylated DNA damage sites to regulate the DDR (promoting BRCA1/53BP1 recruitment and controlling p53 abundance), modulates IFN signaling (serving as a downstream effector of IFN-induced ADP-ribosylation via PARP14 regulation), and promotes antiviral responses by ubiquitylating TBK1 and viral proteases; DTX3L also directly ubiquitylates single-stranded nucleic acids at their 3' ends via its RING-DTC domains.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DTX3L (BBAP) is a RING-type E3 ubiquitin ligase that operates as the catalytic engine of an obligate heterodimer with the macrodomain protein PARP9, coordinating protein ubiquitylation, ADP-ribosylation, and the DNA damage response [#0, #3, #8]. DTX3L homo-oligomerizes through an N-terminal D1–D2 region — its D2 domain crystallizes as a tetramer — while binding PARP9 with nanomolar affinity through a distinct D3 domain; oligomerization is dispensable for heterodimer formation but required for efficient reading of ADP-ribosylated substrates such as the androgen receptor [#10, #15, #19]. The complex carries two opposing enzymatic outputs: classical E3 ligase activity and a PARP9-dependent NAD+-driven mono-ADP-ribosylation of ubiquitin's C-terminal Gly76 that competitively blocks substrate ubiquitylation, a modification reversible by macrodomain hydrolases [#8, #10]. In the DNA damage response, DTX3L-PARP9 is recruited to PARP1-PARylated lesions independently of the ATM/MDC1/RNF8 axis, where DTX3L monoubiquitylates histone H4 at K91 to promote 53BP1 and BRCA1 recruitment, and additionally polyubiquitylates p53 for proteasomal degradation at damage sites [#2, #3, #11]. DTX3L further tunes repair pathway choice by ubiquitylating TIRR (K187) to release 53BP1 and by reciprocally antagonizing the deubiquitinase USP28 [#21, #22]. In immunity, the PARP9-DTX3L complex ubiquitylates histone H2BJ to drive interferon-stimulated gene expression and degrades viral 3C proteases, amplifies type I interferon signaling by K63-ubiquitylating TBK1, and functions as a downstream effector of PARP14-driven IFN-induced ADP-ribosylation [#5, #13, #17]. Beyond protein targets, DTX3L directly ubiquitylates single-stranded DNA and RNA at their 3' ends via its C-terminal RING-DTC domains through ester bond formation [#20]. Across multiple cancers, DTX3L ubiquitylates a broad substrate set — including SATB2, SNAI1, LATS2, PKCα, and NLRP3, and stabilizes EGFR — to modulate proliferation, EMT, and signaling [#12, #16, #23, #25, #26].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Established that DTX3L is an active E3 ubiquitin ligase that dimerizes, answering whether the protein had intrinsic catalytic function and how it assembles.\",\n      \"evidence\": \"In vitro self-ubiquitination assay, yeast two-hybrid, and co-IP showing homo- and heterodimerization with DTX1\",\n      \"pmids\": [\"12670957\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No physiological substrate identified\", \"PARP9 partnership not yet known\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Linked DTX3L to PARP9 (BAL1) by showing it controls the partner's subcellular shuttling, establishing the functional interdependence later defined as obligate heterodimerization.\",\n      \"evidence\": \"Subcellular fractionation and fluorescence microscopy of dynamic shuttling\",\n      \"pmids\": [\"16809771\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Interaction interface not mapped\", \"Enzymatic consequence of partnership undefined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identified histone H4K91 as a specific DTX3L substrate and connected this monoubiquitylation to 53BP1 recruitment, defining a chromatin role in the DNA damage response.\",\n      \"evidence\": \"In vitro ubiquitination, site mutagenesis, ChIP, and 53BP1 foci immunofluorescence\",\n      \"pmids\": [\"19818714\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Recruitment mechanism to damage sites not defined\", \"Relationship to canonical DDR ligases unresolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Placed DTX3L-PARP9 in an ATM/MDC1/RNF8-independent DDR branch recruited via PARP1 PARylation, resolving where the pathway sits relative to canonical signaling.\",\n      \"evidence\": \"Genetic epistasis with knockouts, laser-stripe damage live imaging, co-IP, ubiquitylation assays\",\n      \"pmids\": [\"23230272\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct PAR-binding determinant of recruitment within complex not isolated here\", \"Full substrate repertoire at lesions unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined dual immune effector roles: histone H2BJ ubiquitylation to promote ISG expression and degradation of viral 3C proteases, establishing the complex as an antiviral effector.\",\n      \"evidence\": \"Co-IP, in vitro ubiquitination, STAT1 variant cells, transgenic mouse, viral infection assays\",\n      \"pmids\": [\"26479788\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of STAT1 cooperation not fully resolved\", \"Substrate selectivity rules undefined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Discovered NAD+-dependent ADP-ribosylation of ubiquitin Gly76 by the heterodimer, revealing an autoregulatory switch that competitively inhibits the ligase's own activity.\",\n      \"evidence\": \"Reconstituted ubiquitin processing assay, MS site mapping, mutagenesis, NAD+ titration\",\n      \"pmids\": [\"28525742\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo regulatory significance of the switch not established\", \"Spatial/temporal control of the two activities unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Clarified that PARP9/DTX3L-dependent IFN-induced ADP-ribosylation is a downstream effector rather than a mediator of IFN signaling, and is reversed by SARS-CoV-2 Nsp3 macrodomain.\",\n      \"evidence\": \"Immunofluorescence ADP-ribosylation assay, PARP9/DTX3L knockout cells, Nsp3 ectopic expression\",\n      \"pmids\": [\"34358560\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the relevant transferase not yet resolved here\", \"Functional consequence of the modified targets unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Mapped the modular architecture — D3 domain for nanomolar 1:1 PARP9 binding, N-terminal region for oligomerization — and showed ubiquitin-Gly76 ADP-ribosylation is reversible by macrodomain hydrolases.\",\n      \"evidence\": \"Recombinant protein binding affinity, SEC, in vitro reversal assays\",\n      \"pmids\": [\"35037691\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional role of oligomerization not yet demonstrated\", \"Structural basis of assembly not resolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstrated DTX3L polyubiquitylates p53 at PARylated damage sites to limit its retention, defining a feedback control on DDR signaling intensity.\",\n      \"evidence\": \"Reciprocal co-IP, ubiquitination assay, DTX3L knockout cells, proteasome inhibition, immunofluorescence\",\n      \"pmids\": [\"37096048\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological outcome on p53 transcriptional programs unaddressed\", \"Linkage chain type on p53 not specified\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Expanded the substrate set to immune and signaling regulators — NLRP3, TBK1, cGAS, EGFR — defining DTX3L as a node controlling inflammasome, interferon, and growth-factor pathways.\",\n      \"evidence\": \"Co-IP, domain mapping, site-specific ubiquitination (TBK1 K30/K401), functional pyroptosis/IFN/tumor readouts\",\n      \"pmids\": [\"36706922\", \"37255478\", \"37774567\", \"37460862\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Most substrates from single labs without reciprocal cross-validation\", \"Context-dependence (degradative vs signaling) of each substrate unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Showed dual ADP-ribosylation of closely spaced cysteines generates a high-affinity reader site requiring DTX3L oligomerization, linking oligomeric assembly to substrate recognition.\",\n      \"evidence\": \"Synthetic peptide chemistry, fluorescence binding, oligomerization mutant analysis\",\n      \"pmids\": [\"37939374\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream fate of the recognized androgen receptor not detailed\", \"Generality of the dual-modification readout for other substrates untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Resolved the structural basis of oligomerization (D2 tetramer crystal structure) and mapped KH-like domains mediating PARP9/PARP14/DTX3L interactions, connecting assembly to reader function and ADP-ribosylation regulation.\",\n      \"evidence\": \"X-ray crystallography, native MS, KO reconstitution with D1-D2 deletion, in vitro binding and mutagenesis\",\n      \"pmids\": [\"38511494\", \"38182103\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of the full multi-protein assembly in cells unresolved\", \"Regulation of oligomeric state in vivo unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified PARP14 as the major IFN-induced transferase whose levels and activity are regulated by PARP9/DTX3L, defining the upstream-effector relationship in IFN ADP-ribosylation.\",\n      \"evidence\": \"Improved MAR antibody detection, PARP14/PARP9/DTX3L KO cells, co-localization imaging, biochemical assays\",\n      \"pmids\": [\"38834853\", \"38834852\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional outcome of cytoplasmic inclusion formation unclear\", \"Targets of PARP14 modification relevant to antiviral defense not enumerated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Revealed direct ubiquitylation of single-stranded nucleic acids at 3' ends by the RING-DTC module, establishing a non-protein substrate class for the ligase.\",\n      \"evidence\": \"In vitro ubiquitination with DNA/RNA substrates, NMR, domain truncation, DUB reversal, DTX family comparison\",\n      \"pmids\": [\"39377462\", \"39242775\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular function of nucleic-acid ubiquitylation unknown\", \"In vivo substrates and biological pathway unestablished\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Showed DTX3L ubiquitylates TIRR (K187) to drive its nuclear export and degradation, releasing 53BP1 and biasing repair toward NHEJ with PARP-inhibitor sensitization.\",\n      \"evidence\": \"Co-IP, K187 site mapping, XPO1 inhibition, overexpression/knockdown, PARP inhibitor sensitivity\",\n      \"pmids\": [\"39632881\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Integration with the H4K91/p53 DDR functions not unified\", \"Trigger linking damage to TIRR ubiquitylation unspecified\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Established reciprocal antagonism between DTX3L and USP28 that fine-tunes choice across multiple DSB repair pathways, adding a deubiquitinase counterweight to DTX3L control of repair.\",\n      \"evidence\": \"Reciprocal co-IP, ubiquitination/deubiquitination assays, knockdown epistasis rescue, repair pathway reporters\",\n      \"pmids\": [\"40703443\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometric balance setting the switch unknown\", \"Whether this acts at chromatin or globally unresolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended DTX3L's degradative substrate range in cancer to SATB2 (K266) and LATS2, with competing deubiquitinase USP10 for SATB2, linking DTX3L to glioma stemness and Hippo signaling.\",\n      \"evidence\": \"Co-IP, site-specific ubiquitination, competing-enzyme analysis, rescue, in vivo tumor models\",\n      \"pmids\": [\"41507172\", \"41203184\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"GSK-3β dependence mechanism not fully dissected\", \"Tissue specificity of substrate selection unexplained\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Added SNAI1 and PKCα as degradative substrates controlling EMT and MAPK signaling, with upstream miRNA regulation of DTX3L itself, broadening its role in metastasis suppression and progression.\",\n      \"evidence\": \"Co-IP, ubiquitination assays (K48-linkage for PKCα), miR-135b-5p manipulation, organoid and animal models\",\n      \"pmids\": [\"41972409\", \"41679478\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab findings without reciprocal validation\", \"Reconciliation of pro- and anti-tumor roles across tissues unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How DTX3L selects among its many protein and nucleic-acid substrates, and how the competing ubiquitylation and ubiquitin-ADP-ribosylation activities are spatially and temporally partitioned in cells, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying model for substrate selectivity\", \"In vivo regulation of the ligase-vs-ADP-ribosyltransferase switch undefined\", \"Function of nucleic-acid ubiquitylation in cells unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [8, 17]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 2, 5, 11, 21, 22]},\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [0, 2, 20]},\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [20]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [2, 5]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [20]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [20]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 2, 11]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1, 17]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [2, 3, 11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [2, 3, 11, 21, 22]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [5, 13, 17]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 8, 11]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [2, 5]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [16, 23, 24, 25, 26]}\n    ],\n    \"complexes\": [\n      \"DTX3L-PARP9 heterodimer\",\n      \"DTX3L-PARP9-PARP14 complex\"\n    ],\n    \"partners\": [\n      \"PARP9\",\n      \"PARP14\",\n      \"DTX1\",\n      \"STAT1\",\n      \"USP28\",\n      \"EGFR\",\n      \"TBK1\",\n      \"TIRR\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}